Latest updates
Overview of articles
-
The earnings model of the pharmaceutical industry needs to be overhauledPublished on:Posted in category:Opinion
-
Corona crisis lays bare the need for responsible conduct in dealing with business relationshipsPosted in category:News
Joseph Wilde-RamsingPublished on: -
Responsible disengagement in the time of corona Published on:
Joseph Wilde-RamsingPosted in category:Publication
Joseph Wilde-Ramsing
-
We Can’t Afford Big Pharma’s GreedPosted in category:Opinion
Rodrigo FernandezPublished on:
Rodrigo Fernandez -
Private gains we can ill afford Published on:
Rodrigo FernandezPosted in category:Publication
Rodrigo Fernandez
-
SOMO reveals the financialisation of the pharmaceutical industry and the potentially deadly costsPosted in category:NewsPublished on: -
Brands and retailers need to step up now to protect garment workersPosted in category:NewsPublished on: -
Beyond corporate transparency Published on:
Pauline OvereemPosted in category:Publication
Pauline Overeem
-
-
-
-
Rio Tinto Shareholders: your dividends are plundered bounty from MongoliaPosted in category:Opinion
Rhodante AhlersPublished on:
Rhodante Ahlers -
-
-
Make future corona medicine affordable and accessible for everyonePosted in category:Published on:Statement
-
-
Submission to the UN Open-ended working group on transnational corporations and other business enterprisesPosted in category:Published on:Statement
-
Extraordinary measures can make finance work for societyPosted in category:Opinion
Myriam Vander StichelePublished on:
Myriam Vander Stichele
